Guangzhou Huasheng Pharmaceutical

Guangzhou Huasheng Pharmaceutical Co., Ltd. is the pharmaceutical manufacturing and CDMO subsidiary of Boji Medical Technology (Boji CRO), a prominent Chinese contract research organization. Founded in 2014 and based in Guangzhou, the company operates as the group's primary production facility, offering comprehensive services that include clinical trial medication manufacturing, pilot-scale production, process validation, and Marketing Authorization Holder (MAH) services. The company's GMP-compliant facilities are capable of producing a variety of oral solid dosage forms, such as tablets, capsules, and granules, for both chemical drugs and traditional Chinese medicines. By integrating manufacturing with Boji's clinical research capabilities, Huasheng provides a seamless transition from drug discovery to commercialization for its parent company and external pharmaceutical clients.